This inventor holds 3 USPTO granted patents. Top assignees: Beth Israel Deaconess Medical Center, Inc., Boston University. Active years: 2002-2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Somerville, MA (US) (2002)
- Swampscott, MA (US) (2010 - 2012)
Company Filing History:


Years Active: 2002-2012
Title: Chen-Yu Zhang: Innovator in Pharmaceutical Compositions
Introduction
Chen-Yu Zhang is a notable inventor based in Swampscott, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on genipin derivatives. With a total of three patents to his name, Zhang's research focuses on developing compositions that can aid in treating various medical conditions.
Latest Patents
Zhang's latest patents include groundbreaking work on genipin derivatives and their pharmaceutical applications. These compositions are designed to inhibit the activity of uncoupling protein-2 (UCP2), which is crucial in addressing issues such as deficient first-phase insulin secretion, non-insulin dependent diabetes mellitus, and ischemia in mammals. His research holds promise for improving treatment options for these conditions.
Career Highlights
Throughout his career, Chen-Yu Zhang has worked with esteemed institutions such as Beth Israel Deaconess Medical Center and Boston University. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to significant advancements in pharmaceutical research.
Collaborations
Zhang has collaborated with notable colleagues, including Bradford B. Lowell and John A. Porco, Jr. These partnerships have further enriched his research and have led to the development of innovative solutions in the pharmaceutical industry.
Conclusion
In summary, Chen-Yu Zhang is a distinguished inventor whose work on genipin derivatives has the potential to transform treatment methodologies for various medical conditions. His contributions to the field of pharmaceuticals are noteworthy and continue to inspire future innovations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile